Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Latest news

10/4/2021 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 67% of Russian Doctors Do Not Trust Homeopathic / Release-Active Drugs

Only 6.1% of Russian doctors often recommend homeopathic / release-active drugs to their patients, according to a survey conducted by the RNC Pharma analyst firm and the Doktor Na Rabote (Doctor at Work) social media service for doctors. This group, mainly represented by men aged 46 and above, included doctors of more than 30 specialties, with 40% of them therapists, pediatricians, and neurologists. Another 27% of the respondents say that “the type of the drug does not matter as long as it is clinically effective”. Thus, about 33% of the Russian doctors seem accepting of release-active drugs.

9/29/2021 Pharmaceutical Drug Production in Russia (August 2021)

In January—August 2021, Russian manufacturers produced RUB 384.7 bln worth of pharmaceutical drugs (manufacturer’s prices, VAT included), up 23.2% from January—August 2020. In physical terms, the production volume amounts to 2.65 billion packages, with the growth rate of -14.7%. If calculated in minimum dosage units (MDU), the growth rate is -5%, and the production volume is 51.2 billion MDUs.

9/24/2021 Database Update: Audit of Veterinary Drug Retail Sales in Russia (August 2021)

In January—August 2021, the sales of veterinary drugs in the Russian retail market amounted to 15 billion rubles (retail prices, VAT included), up 5.5% in monetary terms (rubles) from January—August 2020. The inflation rate is still the most important factor for the growth rates. In physical terms, the sales declined, and the growth rate in minimum dosage units (MDU) was 5.1%, with the sales volume of 116.1 million MDUs.

9/20/2021 RNC Pharma Launches New Project “Ranking of Logistics Operators”

The analyst firm RNC Pharma has announced the start of the project “Ranking of Russian Logistics Operators.” The project is being implemented for the first time in order to give a true picture of logistics services in the Russian pharmaceutical market.

9/14/2021 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 53% of Russian Pharmacists Consider General Distrust of Government Campaigns the Reason for Vaccine Hesitancy

More than half of the pharmacists (53%) who took part in the survey conducted by the RNC Pharma analyst firm and the Doktor Na Rabote (Doctor at Work) social media service for doctors believe that “general distrust of government campaigns” is the reason for the development of the anti-vaccination movement. Although the anti-vaccine sentiment does have a long history, the coronavirus pandemic, a set of measures to counter the spread of the virus and rather clumsy activities that were meant to get people to vaccinate were a huge push.

All news [277]

Our competences

RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.